期刊文献+

正常关节软骨和骨关节炎关节软骨细胞中血管活性肠肽表达的比较 被引量:5

Comparison of vasoactive intestinal polypeptide expression between normal and osteoarthritic cartilages
下载PDF
导出
摘要 背景:神经肽的发现给骨关节炎的治疗带来了新的希望,但神经肽的表达与骨关节炎发病以及软骨退变程度的关系尚不清楚。目的:观察血管活性肠肽在正常关节软骨和不同退变程度骨关节炎软骨中的表达,以及血管活性肠肽表达与骨关节炎发病及软骨退变程度的关系。方法:选取2007-03/11中南大学湘雅医院骨科进行关节置换的骨关节炎患者的关节软骨标本26个,选取因外伤行截肢的膝关节软骨或股骨颈暴力骨折的股骨头正常关节软骨标本10个为对照,根据大体观察凿取正常和骨关节炎不同退变程度软骨块50个,再根据关节软骨改良Mankin病理评分法进行分组,采用免疫组织化学染色检测软骨组织中血管活性肠肽的表达和分布。结果与结论:各关节软骨中均可见到血管活性肠肽阳性神经纤维,正常关节软骨中血管活性肠肽的表达明显高于骨关节炎关节软骨(P<0.05)。且血管活性肠肽表达与软骨改良Mankin病理评分呈负相关(r=-0.896,P<0.05)。说明血管活性肠肽低表达与关节软骨退变程度、骨关节炎病程进展有关,可能是关节软骨退变、骨关节炎发病的机制之一。 BACKGROUND:The discovery of neuropeptide provides new hope for the treatment of osteoarthritis,however,the relationship between neuropeptide expression and pathogenesis of osteoarthritis or degeneration of articular cartilage remains poorly understood.OBJECTIVE:To observe the expression of vasoactive intestinal peptide(VIP) in normal and osteoarthritic chondrocytes,and to explore the correlation between VIP and pathogenesis and progression of osteoarthritis.METHODS:Human cartilages were obtained at arthroplasty from 26 patients with osteoarthritis.Meanwhile,articular cartilages were obtained at arthroplasty or amputation for trauma,tumour or infection from 10 patients with no history of arthritis.Then collect 50 cartilage specimens from osteoarthritis and normal joints,all the specimens were grouped according to Mankin pathological score,and the expression and distribution of VIP was detected by immunohistochemical staining.RESULTS AND CONCLUSION:VIP positive nerve fibers existed in both normal and osteoarthritic cartilages.The expression of VIP was greater in normal cartilage than that of the osteoarthritic cartilages(P〈0.05).The VIP expression was negative correlated with Mankin pathological scores(r=-0.896,P〈0.05).The findings demonstrated that,low expression of VIP is concerned with pathogenesis and progression of osteoarthritis,which may be the mechanism for pathogenesis and progression of osteoarthritis.
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2011年第15期2665-2668,共4页 Journal of Clinical Rehabilitative Tissue Engineering Research
  • 相关文献

参考文献21

  • 1Said SI,Mutt V.Isolation from porcine-intestinal wall of a vasoactive octacosapeptide related to secretin and to glucagon.Eur J Biochem.1972;28(2):199-204.
  • 2Sutton S,Clutterbuck A,Harris P,et al.The contribution of the synovium,synovial derived inflammatory cytokines and neuropeptides to the pathogenesis of osteoarthritis.Vet J.2009; 179(1):10-24.
  • 3Juarranz Y,Abad C,Martinez C,et al.Protective effect of vasoactive intestinal peptide on bone destruction in the collagen-induced arthritis model of rheumatoid arthritis.Arthritis Res Ther.2005;7(5):R1034-1045.
  • 4Delgado M,Gonzalez-Rey E,Ganea D.VIP/PACAP preferentially attract Th2 effectors through differential regulation of chemokine production by dendritic cells.FASEB J.2004;18(12):1453-1455.
  • 5Gutiérrez-Ca(n)as I,Juarranz Y,Santiago B,et al.VIP down-regulates TLR4 expression and TLR4-mediated chemokine production in human rheumatoid synovial fibroblasts.Rheumatology (Oxford).2006;45(5):527-532.
  • 6McDougall JJ,Watkins L,Li Z.Vasoactive intestinal peptide (VIP) is a modulator of joint pain in a rat model of osteoarthritis.Pain.2006; 123(1-2):98-105.
  • 7Schuelert N,McDougall JJ.Electrophysiological evidence that the vasoactive intestinal peptide receptor antagonist VIP6-28 reduces nociception in an animal model of osteoarthritis.Osteoarthritis Cartilage.2006;14(11):1155-1162.
  • 8Murphy WA Jr,Altman RD.Updated osteoarthritis reference standard.J Rheumatol Suppl.1995;43:56-59.
  • 9Outerbridge RE,Dunlop JA.The problem of chondromalacia patellae.Clin Orthop Relat Res.1975;(110):177-196.
  • 10Mankin HJ,Dorfman H,Lippiello L,et al.Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips.II.Correlation of morphology with biochemical and metabolic data.J Bone Joint Surg Am.1971;53(3):523-537.

二级参考文献6

  • 1Ficat RP,Arlet J. 苏国礼,胡清潭,译 .骨缺血与坏死 . 第 1版 . 上海:上海翻译出版公司 , 1989. 6-7.
  • 2Kjaer I. Correlated appearance of ossification and nerve tissue in human fetal jaws. J Craniofac Genet Dev Biol, 1990, 10:329- 336.
  • 3Kjaer I. Neuro osteology. Crit Rev Oral Biol Med, 1998, 9:224-244.
  • 4Bjurholm A, Kreicbergs A, Tereniius L, et al. Neuropeptide Y , tyrosine hydroxylase and vasoactive intestinal polypeptide immunoreactive nerves in bone and surrounding tissues. J Auton Nerv Syst,1988, 25:119-125.
  • 5Lindblad BE, Nielsen LB, Jespersen SM, et al. Vasoconstrictive action of neuropeptide Y in bone. The porcine tibia perfused in vivo. Acta Orthop Scand, 1994, 65: 629-634.
  • 6Ahmed M, Bjurholm A, Kreicbergs A, et al. Neuropeptide Y, tyrosine hydroxylase and vasoactive intestinal polypeptide immunoreactive nerve fibers in the vertebral bodies, discs, dura mater, and spinal ligaments of the rat lumbar spine. Spine, 1993, 18:268-273.

共引文献60

同被引文献60

  • 1王伟,李伟毅.血管活性肠肽的免疫调节作用[J].细胞生物学杂志,2005,27(2):148-152. 被引量:15
  • 2邱贵兴,翁习生,张克,周乙雄,娄思权,王以朋,李为,张洪,刘岩.盐酸/硫酸氨基葡萄糖治疗骨关节炎的平行对照临床研究[J].中华医学杂志,2005,85(43):3067-3070. 被引量:93
  • 3刘晓青,崔燎,吴铁.双侧卵巢切除大鼠不同时间段骨形态计量学参数的观察[J].中国骨质疏松杂志,2005,11(4):427-429. 被引量:15
  • 4Dharmapatni AA, Smith MD, Crotti TN. TWEAK andFnl4 expression in the pathogenesis of joint inflammationand bone erosion in rheuma-toid arthritis [ J], ArthritisRes Ther,2011,13(2) :R51-R54.
  • 5Galich AL,Domiciano DS, Fuller R, et al. Osteoarthritis:can anti-cytokine therapy play a role in treatment[J], ClinRheumatol,2010,29(5) =451-460.
  • 6Centers for Disease Control and Prevention (CDQ. Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation-UnitedStates,2010-2012[J]. MMWR Morb Mortal Wkly Rep, 2013, 62(44):869-873.
  • 7胥少丁,葛宝丰,徐印欢.实用骨科学(第三版)[M].北京:人民军医出版社,2006:1198.
  • 8Sacitharan PK, Snelling SJ,Edwards JR. Aging mechanisms inarthritic disease[J]. Discov Med, 2012, 14(78):345-352.
  • 9Bultink IE, Lems WF. Osteoarthritis and osteoporosis: what is theoverlap?[J]. Curr Rheumatol Rep, 2013,15(5):328.
  • 10Shanthanagouda AH, Guo BS, Ye RR, et al. Japanese medaka: anon-mammalian vertebrate model for studying sex and age-relatedbone metabolism in vivo[J]. PLoS One, 2014, 9(2):e88165.

引证文献5

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部